Recurring somatic gene mutations in HNSCC have been identified, including those in high frequencies (e.g., TP53 mutations occur in the majority of non-HPV HNSCC), making these potential targets for ctDNA approaches. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.